- Home
- LGND vs IRON Comparison
LGND vs IRON Comparison
Compare LGND & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- IRON
- Stock Information
- Founded
- LGND 1987
- IRON 2017
- Country
- LGND United States
- IRON United States
- Employees
- LGND N/A
- IRON N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- LGND Health Care
- IRON Health Care
- Exchange
- LGND Nasdaq
- IRON Nasdaq
- Market Cap
- LGND 2.3B
- IRON 1.9B
- IPO Year
- LGND 1992
- IRON N/A
- Fundamental
- Price
- LGND $111.89
- IRON $58.25
- Analyst Decision
- LGND Strong Buy
- IRON Strong Buy
- Analyst Count
- LGND 6
- IRON 10
- Target Price
- LGND $145.00
- IRON $73.70
- AVG Volume (30 Days)
- LGND 124.3K
- IRON 267.1K
- Earning Date
- LGND 02-25-2025
- IRON 11-12-2024
- Dividend Yield
- LGND N/A
- IRON N/A
- EPS Growth
- LGND 160.46
- IRON N/A
- EPS
- LGND 2.47
- IRON N/A
- Revenue
- LGND $152,422,000.00
- IRON N/A
- Revenue This Year
- LGND $26.86
- IRON N/A
- Revenue Next Year
- LGND $14.95
- IRON N/A
- P/E Ratio
- LGND $45.27
- IRON N/A
- Revenue Growth
- LGND N/A
- IRON N/A
- 52 Week Low
- LGND $67.72
- IRON $25.60
- 52 Week High
- LGND $129.90
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- LGND 50.22
- IRON 40.61
- Support Level
- LGND $102.79
- IRON $57.09
- Resistance Level
- LGND $112.61
- IRON $61.08
- Average True Range (ATR)
- LGND 4.01
- IRON 2.83
- MACD
- LGND 0.39
- IRON -0.58
- Stochastic Oscillator
- LGND 87.67
- IRON 14.04
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.